Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

No studies found 1 · 50%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 50%Moderate 0 · 0%High 0 · 0%

Recurrence · People with American cutaneous and mucocutaneous leishmaniasis

Oral miltefosine (50 mg for 28 days) showed no clear difference in recurrence compared with placebo (same regimen) (low certainty).

1 finding from 1 review

Interventions for American cutaneous and mucocutaneous leishmaniasis 2020 · Cochrane Headline outcomes only
RR 2.97 [0.37, 23.89]
1 study · 133 participants
Low

Recurrence ‐ not measured · People with American cutaneous and mucocutaneous leishmaniasis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for American cutaneous and mucocutaneous leishmaniasis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found